Takeda Pharmaceutical Company Limited (TSE: 4502)
Health Care · Pharmaceuticals · JP
¥5,843.00
+0.46% today · +34.8% 1Y
Takeda Pharmaceutical Company Limited (TSE: 4502) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $58.92B and employs 47,029 people.
Over the last twelve months the share price has gained 34.8%, trading between 4.10K and 6.03K.
Tweenvest scores Takeda Pharmaceutical Company Limited across four factors: quality 66/100, value 27/100, growth 8/100, dividend 62/100. Its strongest factor is quality.
4502 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $58.92B
- Revenue (TTM)
- $28.42B
- P/E
- —
- EPS
- -103.52
- Dividend yield
- 3.51%
- Beta (5Y)
- 0.10
- 52-week high
- ¥6,033.00
- 52-week low
- ¥4,102.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.60B
- Employees
- 47,029
- Next earnings
- —
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
- ISIN
- JP3463000004
- Founded
- 1781
- Listed since
- May 16, 1949
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SanofiENXTPA: SAN | $95.94B | €71.62 | +0.14% |
| GSK plcLSE: GSK | $92.79B | £17.61 | +0.63% |
| Merck KGaAXTRA: MRK | $67.11B | €138.40 | +0.40% |
| Chugai Pharmaceutical Co., Ltd.TSE: 4519 | $62.54B | ¥6,019.00 | -1.44% |
| Bayer AktiengesellschaftXTRA: BAYN | $48.15B | €43.73 | -0.09% |
| Teva Pharmaceutical Industries LimitedNYSE: TEVA | $47.89B | $41.37 | +0.66% |
| Galderma Group AGSWX: GALD | $46.30B | CHF168.65 | +2.24% |
| Jiangsu Hengrui Pharmaceuticals Co.,LtdSHSE: 600276 | $46.07B | CN¥46.85 | -0.34% |
Figures last refreshed Oct 11, 2026.